Literature DB >> 718258

HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onset.

W Brenner, F Gschnait, W R Mayr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 718258     DOI： 10.1007/bf00447371

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  4 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  HLA C and D antigens associated with psoriasis.

Authors:  A J McMichael; V Morhenn; R Payne; T Sasazuki; E M Farber
Journal:  Br J Dermatol       Date:  1978-03       Impact factor: 9.302

3.  HL-A antigens in psoriasis with special reference to the clinical type, age of onset, exacerbations after respiratory infections and occurrence of arthritis.

Authors:  J Karvonen
Journal:  Ann Clin Res       Date:  1975-10

4.  Psoriasis: case rate--HL-A antigen frequency correlations.

Authors:  R J Thomas
Journal:  Dermatologica       Date:  1977
  4 in total
  8 in total

1.  Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201.

Authors:  I Ikaheimo; S Silvennoinen-Kassinen; J Karvonen; T Jarvinen; A Tiilikainen
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

2.  Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis.

Authors:  H Nakagawa; S Akazaki; A Asahina; K Tokunaga; K Matsuki; S Kuwata; Y Ishibashi; T Juji
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Lucus B HLA antigens in psoriatic patients. Population and family studies and clinical relationship.

Authors:  G Turowski; J J Pietrzyk; M Kapińska-Mrówka
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

Review 4.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

5.  HLA risk haplotype Cw6,DR7,DQA1*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris.

Authors:  I Ikäheimo; A Tiilikainen; J Karvonen; S Silvennoinen-Kassinen
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

Review 6.  Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.

Authors:  Yu Ri Woo; Dae Ho Cho; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2017-12-11       Impact factor: 5.923

7.  HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Peter Kozub; Mária Zilínková; Peter Frey; Stanislav Ferenčík; Milan Buc
Journal:  Folia Microbiol (Praha)       Date:  2012-11-27       Impact factor: 2.099

8.  Efficacy of gabapentin in the improvement of pruritus and quality of life of patients with notalgia paresthetica.

Authors:  Ana Alice Wolf Maciel; Paulo Rowilson Cunha; Isabela Ortiz Laraia; Flávia Trevisan
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.